STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter Methylation
Clinical trial NCT07754734 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07754734
- Sponsor
- Dongguan People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-10
- Primary completion
- 2029-07-31
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.